Neuron-specific enolase and thymidine kinase as an aid to the diagnosis and treatment monitoring of small cell lung cancer

Lung Cancer ◽  
1989 ◽  
Vol 5 (2-3) ◽  
pp. 108
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Thymidine Kinase ◽  
Cell Lung Cancer ◽  
Neuron Specific Enolase ◽  
Treatment Monitoring ◽  
Small Cell ◽  
Diagnosis And Treatment ◽  
Small Cell Lung

Serum NSE, CEA, CT, CA 15-3 Levels in Human Lung Cancer

1990 ◽  
Vol 5 (4) ◽  
pp. 198-202 ◽  
Author(s):  
S. Nutini ◽  
G. Cappelli ◽  
A. Benucci ◽  
C. Catalani ◽  
F. Nozzoli
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Neuron Specific Enolase ◽  
Treatment Monitoring ◽  
Small Cell ◽  
Human Lung Cancer ◽  
Small Cell Lung ◽  
Lung Cancers ◽  
Low Sensitivity

The significance of neuron specific enolase (NSE) was investigated in comparison with other tumor markers (CEA, CT, CA 15-3) used in the diagnosis and treatment monitoring of lung cancer. As previously described, the calcitonin assay proved to have very low sensitivity for small cell lung cancer (SCLC). The serum NSE assay was, however, shown to be a useful diagnostic aid for discrimination between histologically different lung cancers, and therefore this assay may be a valuable tool for treatment monitoring in SCLC patients. CA 15-3, also an unspecific marker, showed similar sensitivity to the NSE assay in SCLC patients, the sensitivity being higher than CEA in non small cell lung cancer (NSCLC)

SERUM NEURON-SPECIFIC ENOLASE: A MARKER FOR DISEASE EXTENT AND RESPONSE TO THERAPY OF SMALL-CELL LUNG CANCER

The Lancet ◽  
1982 ◽  
Vol 319 (8272) ◽  
pp. 583-585 ◽  
Author(s):  
DesmondN Carney ◽  
DanielC Ihde ◽  
MartinH Cohen ◽  
PaulJ Marangos ◽  
PaulA Bunn ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Neuron Specific Enolase ◽  
Small Cell ◽  
Response To Therapy ◽  
Small Cell Lung ◽  
Disease Extent ◽  
Serum Neuron Specific Enolase
Sign in / Sign up

Export Citation Format

Share Document